
Li Zhang, MD, discusses sacituzumab tirumotecan in patients with previously treated, advanced EGFR-mutated non–small cell lung cancer.

Your AI-Trained Oncology Knowledge Connection!

Li Zhang, MD, is the deputy director of the Lung Cancer Research Center and a professor in the Medical Oncology Department at Sun Yat-sen University Cancer Center.